Revised forecast
Fiscal year ending March 2027 · Second quarter (interim period) and full yearPrevious forecast published 6 August 2026The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
For the interim period, operating profit is expected to exceed the previous forecast due to higher-than-expected service revenue in the Precision Equipment Business, benefiting from strong semiconductor market conditions; lower selling, general and administrative expenses resulting from cost controls and the deferral of certain expenditures; and tariff refunds in the United States and other factors. For the full year, revenue was revised down following a review of the Imaging Business's sales plan for the second half, while profit forecasts for the Precision Equipment, Healthcare and Industry businesses were raised.
| Item | Details |
|---|---|
| Net Sales | Second quarter (interim period) 336,000 / Full year 732,000 → Second quarter (interim period) 334,500 / Full year 722,000（Second quarter (interim period) △0.4% / Full year △1.4%） |
| Operating profit | Second quarter (interim period) -5,500 / Full year 11,000 → Second quarter (interim period) 9,000 / Full year 16,500（Second quarter (interim period) Not disclosed / Full year 50.0%） |
| Profit attributable to owners of the parent | Second quarter (interim period) -2,500 / Full year 10,000 → Second quarter (interim period) 10,500 / Full year 16,000（Second quarter (interim period) Not disclosed / Full year 60.0%） |
| Net income per share | Second quarter (interim period) -7.59 / Full year 30.36 → Second quarter (interim period) 31.87 / Full year 48.57 |
| Fiscal Period Covered | Fiscal year ending March 2027 |
| Period Covered | Second quarter (interim period) and full year |
| Publication date of previous forecast | 6 August 2026 |
| Previous-period results | Second quarter (interim period) Revenue ¥312,915 million, operating loss ¥4,829 million, loss before tax ¥5,265 million, interim profit attributable to owners of the parent ¥5,356 million, basic interim earnings per share ¥16.28 / Full year Revenue ¥677,163 million, operating loss ¥112,448 million, loss before tax ¥106,511 million, net loss attributable to owners of the parent ¥86,088 million, basic earnings per share ¥261.57 loss |
| Reason for the revision | For the interim period, operating profit is expected to exceed the previous forecast due to higher-than-expected service revenue in the Precision Equipment Business, benefiting from strong semiconductor market conditions; lower selling, general and administrative expenses resulting from cost controls and the deferral of certain expenditures; and tariff refunds in the United States and other factors. For the full year, revenue was revised down following a review of the Imaging Business's sales plan for the second half, while profit forecasts for the Precision Equipment, Healthcare and Industry businesses were raised. |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (3)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.For the interim period, operating profit is expected to improve due to higher-than-expected service revenue in the Precision Equipment Business, benefiting from strong semiconductor market conditions; lower selling, general and administrative expenses resulting from cost controls and the deferral of certain expenditures; and tariff refunds in the United States. For the full year, revenue was revised down following a review of the Imaging Business's sales plan for the second half, while profit forecasts for the Precision Equipment, Healthcare and Industry businesses were raised.